ACCC 29th National Oncology Conference
This oncology meeting—more than any other—offered fresh ideas and empowering strategies attendees could take home and immediately implement. Read on below for highlights from the conference.
To learn how you can access all of the conference sessions online through ACCC's Virtual National Oncology Conference, click here.
Trading "Yeah, Buts" for "What Ifs?" and "Why Nots?"
Kevin Freiberg, EdD
"Your cause is heroic. Your work is a crusade. What you do matters," keynote speaker Kevin Freiberg, EdD, told ACCC National Oncology Conference attendees at this morning's opening session. "And I think every cancer center in this room has to be prepared to accelerate innovation."
Dr. Kevin Freiberg has been profiling revolutionary business leaders in some of the world’s most innovative companies for more than 20 years. He is an influential voice for his views on the critical links between leadership, corporate culture, innovation, and exceptional loyalty.
In his energizing keynote presentation, Dr. Freiberg shared stories of innovations from the oncology world and beyond that can be catalysts for inspiration and new ideas in cancer centers across the country. For more, visit our blog.
Transformations, Collaborations, and Options
Looking to the future, Matt Farber, ACCC’s director of policy & provider economics, (far left) facilitated a discussion on “Transformations, Collaborations, and Options in the New World of Oncology Payment.” Panelists (L to R) Kurt H. Neumann, MD, ION Solutions; Edwin Rodgers, Via Oncology Pathways; George Kovach, MD, President, ACCC; and Thomas L. Whittaker, MD, IU Health Central Indiana Cancer Centers were in agreement that pathways, guidelines, medical homes, and ACOs will likely evolve in combination with no one methodology holding sway. For community-based practices, the consensus was that a strong leader, collaboration with other providers, and demonstration of quality and value are key to survival.
For more insights from the panel discussion, read our blog.
2012 ACCC Innovator Awards
The 2012 ACCC Innovator Award winners shared their pioneering programs, tools, and replicable models at the National Oncology Conference. Their sessions showcased their achievements, from developing a model breast cancer program across a large health system, to addressing the needs of head and neck cancer patients through a team approach.
Nurse Researcher Donna Berry Received 2012 ACCC Outstanding Achievement in Clinical Research Award
Donna Berry, PhD, RN, AOCN, FAAN, received the 2012 ACCC Outstanding Achievement in Clinical Research Award during the 29th National Oncology Conference.
“I think about my career as asking two questions: ‘Why?’ and ‘Why not?’ It epitomizes what I’ve done,” she told attendees during a luncheon in her honor. Dr. Berry is director of the Phyllis F. Cancer Center for Nursing & Patient Care Services at the Dana-Farber Cancer Institute and an associate professor of medicine at Harvard Medical School.
Characterizing her work as a lifetime of inquiry, Dr. Berry said she has asked these questions with one consistent goal: to maximize health outcomes for individuals with cancers. The same goal shared by “everyone of you in this room.” In her remarks, Dr. Berry emphasized the importance of collaboration in translating research into the clinical care setting. “…I can tell you in taking care of people with cancer in the clinical setting, we do not isolate ourselves,” she said. “We stand shoulder to shoulder,” she said.
Oncology Pharmacy Education Network Pre-Conference
Designed for oncology pharmacists and administrators, ACCC’s Oncology Pharmacy Education Network (OPEN) Pre-Conference explored the latest trends in pharmacy practice, including clinical and management issues facing the oncology pharmacy.